Chronic Kidney Disease (CKD)
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age=>18 years 2. History of medical visits to the participating institutions between April 2019 and May 2025 3. Diagnosed with CKD according to the Japanese Guideline for CKD 2023 4. Continuously administered Shichimotsukokato for at least one year 5. Availability of blood test data, including eGFR at three time points (one year before initiation, at initiation, and one year after initiation of Shichimotsukokato)
Exclusion criteria
Exclusion criteria: Individuals who refuse to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| eGFR slope before and after one year of Shichimotsukokato administration | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in SBP, DBP, and urinary protein before and after one year treatment Adverse events | — |
Countries
Japan
Contacts
Aizu Medical Center, Fukushima Medical University Department of Kampo Medicine